The future of antibiotic: From the magic bullet to the smart bullet

Journal of Microbial and Biochemical Technology

Volumn 6, Issue 5, 2014, Pages

  Cascioferro, Stella ^a   Schillaci, Domenico ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE INHIBITOR; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; LIPOTEICHOIC ACID; MEMBRANE PROTEIN; MICROBIAL SURFACE COMPONENTS RECOGNIZING ADHESIVE MATRIX MOLECULE; N (4 CHLOROPHENYL) 2 [5 [4 (PYRROLIDINE 1 SULFONYL)PHENYL][1,3,4]OXADIAZOL 2 YL SULFANYL]ACETAMIDE; PEPTIDYLCHLOROMETHANE DERIVATIVE; PEPTIDYLDIAZOMETHANE DERIVATIVE; PILICIDE; POLYPEPTIDE ANTIBIOTIC AGENT; PYRAZOLE DERIVATIVE; PYRAZOLETHIONE; PYRIDAZINONE DERIVATIVE; RHODANINE; SORTASE; SORTASE A; TEICHOIC ACID; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM PILUS; BIOFILM; BIOTECHNOLOGY; DRUG RESEARCH; EDITORIAL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; HUMAN; IMMUNOMODULATION; INFECTION; NONHUMAN;

EID: 84906966678     PISSN: None     EISSN: 19485948     Source Type: Journal    
DOI: 10.4172/1948-5948.1000e118     Document Type: Editorial

References (30)

1. Rasko DA, Sperandio V (2010) Anti-virulence strategies to combat bacteriamediated disease. Nat Rev Drug Discov 9: 117-128.
2. Maresso AW, Schneewind O (2008) Sortase as a target of anti-infective therapy. Pharmacol Rev 60: 128-141.
3. Breines DM, Burnham JC (1994) Modulation of Escherichia coli type 1 fimbrial expression and adherence to uroepithelial cells following exposure of logarithmic phase cells to quinolones at subinhibitory concentrations. J Antimicrob Chemother 34: 205-221.
4. Piatek R, Zalewska-Piatek B, Dzierzbicka K, Makowiec S, Pilipczuk J, et al. (2013) Pilicides inhibit the FGL chaperone/usher assisted biogenesis of the Dr fimbrial polyadhesin from uropathogenic Escherichia coli. BMC Microbiol 13: 131.
5. Cegelski L, Pinkner JS, Hammer ND, Cusumano CK, Hung CS, et al. (2009) Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat Chem Biol 5: 913-919.
6. Svensson A, Larsson A, Emtena¨s H, Hedenstro¨m M, Fex T, et al. (2001) Design and evaluation of pilicides: potential novel antibacterial agents directed against uropathogenic Escherichia coli. Chembiochem 2: 915-918.
7. Pinkner JS, Remaut H, Buelens F, Miller E, Aberg V, et al. (2006) Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proc Natl Acad Sci U S A 103: 17897-17902.
8. Lo AW, Van de Water K, Gane PJ, Chan AW, Steadman D, et al. (2014) Suppression of type 1 pilus assembly in uropathogenic Escherichia coli by chemical inhibition of subunit polymerization. J Antimicrob Chemother 69: 1017-1026.
9. Vengadesan K, Narayana SV (2011) Structural biology of Gram-positive bacterial adhesins. Protein Sci 20: 759-772.
10. Chen L, Wen YM (2011) The role of bacterial biofilm in persistent infections and control strategies. Int J Oral Sci 3: 66-73.
11. Kim SH, Shin DS, Oh MN, Chung SC, Lee JS, et al. (2003) Inhibition of sortase, a bacterial surface protein anchoring transpeptidase, by beta-sitosterol-3-Oglucopyranoside from Fritillaria verticillata. Biosci Biotechnol Biochem 67: 2477-2479.
12. Kang SS, Kim JG, Lee TH, Oh KB (2006) Flavonols inhibit sortases and sortase-mediated Staphylococcus aureus clumping to fibrinogen. Biol Pharm Bull 29: 1751-1755.
13. Park BS, Kim JG, Kim MR, Lee SE, Takeoka GR, et al. (2005) Curcuma longa L. constituents inhibit sortase A and Staphylococcus aureus cell adhesion to fibronectin. J Agric Food Chem 53: 9005-9009.
14. Hu P, Huang P, Chen WM (2013) Curcumin inhibits the Sortase A activity of the Streptococcus mutans UA159. Appl Biochem Biotechnol 171: 396-402.
15. Hu P, Huang P, Chen MW (2013) Curcumin reduces Streptococcus mutans biofilm formation by inhibiting sortase A activity. Arch Oral Biol 58: 1343-1348.
16. Kim SH, Shin DS, Oh MN, Chung SC, Lee JS, et al. (2004) Inhibition of the bacterial surface protein anchoring transpeptidase sortase by isoquinoline alkaloids. Biosci Biotechnol Biochem 68: 421-424.
17. Oh I, Yang WY, Chung SC, Kim TY, Oh KB, et al. (2011) In vitro sortase A inhibitory and antimicrobial activity of flavonoids isolated from the roots of Sophora flavescens. Arch Pharm Res 34: 217-222.
18. Oh KB, Mar W, Kim S, Kim JY, Oh MN, et al. (2005) Bis(indole) alkaloids as sortase A inhibitors from the sponge Spongosorites sp. Bioorg Med Chem Lett 15: 4927-4931.
19. Jang KH, Chung SC, Shin J, Lee SH, Kim TI, et al. (2007) Aaptamines as sortase A inhibitors from the tropical sponge Aaptos aaptos. Bioorg Med Chem Lett 17: 5366-5369.
20. Jeon JE, Na Z, Jung M, Lee HS, Sim CJ, et al. (2010) Discorhabdins from the Korean marine sponge Sceptrella sp. J Nat Prod 73: 258-262.
21. Bae J, Jeon JE, Lee YJ, Lee HS, Sim CJ, et al. (2011) Sesterterpenes from the tropical sponge Coscinoderma sp. J Nat Prod 74: 1805-1811.
22. Won TH, Jeon JE, Kim SH, Lee SH, Rho BJ, et al. (2012) Brominated aromatic furanones and related esters from the ascidian Synoicum sp. J Nat Prod 75: 2055-2061.
23. Won TH, Jeon JE, Lee SH, Rho BJ, Oh KB, et al. (2012) Beta-carboline alkaloids derived from the ascidian Synoicum sp. Bioorg Med Chem 20: 4082- 4087.
24. Scott CJ, McDowell A, Martin SL, Lynas JF, Vandenbroeck K, et al. (2002) Irreversible inhibition of the bacterial cysteine protease-transpeptidase sortase (SrtA) by substrate-derived affinity labels. Biochem J 366: 953-958.
25. Connolly KM, Smith BT, Pilpa R, Ilangovan U, Jung ME, et al. (2003) Sortase from Staphylococcus aureus does not contain a thiolate-imidazolium ion pair in its active site. J Biol Chem 278: 34061-34065.
26. Suree N, Yi SW, Thieu W, Marohn M, Damoiseaux R, et al. (2009) Discovery and structure-activity relationship analysis of Staphylococcus aureus sortase A inhibitors. Bioorg Med Chem 17: 7174-7185.
27. Swoboda JG, Campbell J, Meredith TC, Walker S (2010) Wall teichoic acid function, biosynthesis, and inhibition. Chembiochem 11: 35-45.
28. Rahman O, Dover LG, Sutcliffe IC (2009) Lipoteichoic acid biosynthesis: two steps forwards, one step sideways? Trends Microbiol 17: 219-225.
29. Marr AK, Gooderham WJ, Hancock RE (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6: 468- 472.
30. Wilmes M, Cammue BP, Sahl HG, Thevissen K (2011) Antibiotic activities of host defense peptides: more to it than lipid bilayer perturbation. Nat Prod Rep 28: 1350-1358.